Quarterly report · Q3
7446.TEDINET S100OW0Q
Period2021-10-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.9bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥36.2bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.2bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥763m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥572m | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥814m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥759m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥608m | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥786m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥612m | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥539m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥517m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥428m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥559m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥446m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥15.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥16.2bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥9.8bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.6bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥799m | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥596.99 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥185.03 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥564.91 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥467.38 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.17 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.3% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2021-10-01 → 2022-06-30 | ¥318m |
| Otherother segments | revenue external | 2021-10-01 → 2022-06-30 | ¥318m |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥2.4bn |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥2.4bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥13.8bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥13.8bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥11.4bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-06-30 | ¥27.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-06-30 | ¥27.9bn |
| Otherother segments | revenue | 2020-10-01 → 2021-06-30 | ¥331m |
| Otherother segments | revenue external | 2020-10-01 → 2021-06-30 | ¥331m |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥2.5bn |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥2.5bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥10.9bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-06-30 | ¥27.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-06-30 | ¥27.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 381
| Item | Context | Value | Unit |
|---|---|---|---|
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)青森県弘前市大字神田一丁目３番地の１ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)0172 (33) 8131 (代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)上席執行役員管理グループ長 磯辺 譲 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)青森県弘前市大字神田一丁目３番地の１ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)0172 (33) 8131 (代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)上席執行役員管理グループ長 磯辺 譲 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02810 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 74460 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)東北化学薬品株式会社 | |
| Filer name in english | FilingDateInstant | TOHOKU CHEMICAL CO.,LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2021-10-01 | |
| Current period end date | FilingDateInstant | 2022-06-30 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2022-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2020-10-01 | |
| Comparative period end date | FilingDateInstant | 2021-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2021-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |